CNS PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • July 26th, 2024 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), as follows:
WAIVER AND CONSENT AGREEMENTWaiver and Consent Agreement • July 26th, 2024 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Waiver and Consent Agreement dated as of July 25, 2024 (the “Agreement”) is by and between CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and the undersigned Purchasers (as defined below) identified on the signature pages hereto. Capitalized terms not defined herein shall have the meanings assigned to them in that certain Securities Purchase and Exchange Agreement (the “SPA”) dated as of January 29, 2024 by and among the Company and each purchaser identified on the signature pages thereto (each, a “Purchaser” and collectively, the “Purchasers”).
